Literature DB >> 8654116

High total TGF-beta 2 levels in normal human tears.

N Kokawa1, C Sotozono, K Nishida, S Kinoshita.   

Abstract

Mature and total TGF-beta 2 levels were determined in normal human tears, from 37 volunteers, using a quantitative "sandwich' enzyme immunoassay technique. Since this ELISA method recognizes only mature TGF-beta 2, total TGF-beta 2 levels in tears were measured after acid activation. Aqueous humor samples from 9 patients with cataract were also tested as controls. Mature and total TGF-beta 2 in aqueous humor (AH) averaged 182 pg/ml and 737 pg/ml, respectively. The levels of mature TGF-beta 2 in normal human tears ranged from 36 to 71 pg/ml (mean: 55 pg/ml). And the levels of total TGF-beta 2 ranged from 3446 to 14910 pg/ml (mean: 7854 Pg/ml), a very high level. Percentage of mature TGF-beta 2 ranged 0.4 to 1.3% (mean: 0.9%). It is reported for the first time that there are very high levels of total TGF-beta 2 in normal human tears.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8654116     DOI: 10.3109/02713689609007630

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  11 in total

1.  Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells.

Authors:  Zhuo Chen; De-quan Li; Louis Tong; Paul Stewart; Claire Chu; Stephen C Pflugfelder
Journal:  Mol Vis       Date:  2006-08-23       Impact factor: 2.367

Review 2.  Biological functions of tear film.

Authors:  Stephen C Pflugfelder; Michael E Stern
Journal:  Exp Eye Res       Date:  2020-06-16       Impact factor: 3.467

3.  Application of autologous serum eye drops after pterygium surgery: a prospective study.

Authors:  Sabahattin Sul; Safak Korkmaz; Goksu Alacamli; Pelin Ozyol; Erhan Ozyol
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-18       Impact factor: 3.117

4.  Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes.

Authors:  Seong Hee Min; Tong-Il Lee; Yun Seok Chung; Hwang Ki Kim
Journal:  Korean J Ophthalmol       Date:  2006-09

5.  TGFβ1 and TGFβ2 proteins in corneas with and without stromal fibrosis: Delayed regeneration of apical epithelial growth factor barrier and the epithelial basement membrane in corneas with stromal fibrosis.

Authors:  Rodrigo Carlos de Oliveira; George Tye; Lycia Pedral Sampaio; Thomas Michael Shiju; JodiRae DeDreu; A Sue Menko; Marcony R Santhiago; Steven E Wilson
Journal:  Exp Eye Res       Date:  2020-10-22       Impact factor: 3.467

6.  Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies.

Authors:  Francesco Semeraro; Eliana Forbice; Osvaldo Braga; Alessandro Bova; Attilio Di Salvatore; Claudio Azzolini
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

7.  Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome.

Authors:  I-Hsin Ma; Lily Wei Chen; Wen-Hui Tu; Chia-Ju Lu; Chien-Jung Huang; Wei-Li Chen
Journal:  Taiwan J Ophthalmol       Date:  2017 Oct-Dec

8.  Association of TGFB -509C>T promoter polymorphism with primary angle closure glaucoma in a North Indian Punjabi cohort.

Authors:  Nanamika Thakur; Rajeev Kumar Pandey; Rashim Mannan; Archna Pruthi; Sanjana Mehrotra
Journal:  BMC Ophthalmol       Date:  2021-04-08       Impact factor: 2.209

9.  Significant Association and Increased Risk of Primary Open Angle Glaucoma with TGFB2 Rs991967 Gene Polymorphism in North Eastern Iranian Patients.

Authors:  Akbar Derakhshan; Javad Sadeghi Allah Abadi; Jalil Tavakkol-Afshari; Amin Reza Nikpoor; Ramin Daneshvar; Saeed Shokoohi Rad; Mohammad-Reza Ansari-Astaneh; Sadegh Ghafarian
Journal:  Rep Biochem Mol Biol       Date:  2019-01

10.  Conjunctival TGF-B Level in Primary Augmented Trabeculectomy.

Authors:  Guan Fook Ng; Ishak Siti Raihan; Yaakub Azhany; Che Hussin Che Maraina; K Gurusamy Banumathi; Tajudin Liza-Sharmini
Journal:  Open Ophthalmol J       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.